Eloralintide
A Study of Macupatide (LY3532226) in Participants With Obesity or Overweight Without Type 2 Diabetes
Eli Lilly · Phase 1 · Not yet recruiting · Enrollment 60
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.